oxycodone controlled-release + oxycodone immediate-release

A combination therapy consisting of **oxycodone controlled-release** (CR) and **oxycodone immediate-release** (IR), both small molecule opioid agonists. This regimen leverages CR oxycodone to provide a stable plasma concentration for continuous, around-the-clock analgesia typically taken every 12 hours, and IR oxycodone for supplemental or breakthrough pain relief, typically administered every 4 to 6 hours. The combination is used for management of **moderate to severe pain**—such as cancer pain and chronic osteoarthritis—that requires both sustained baseline analgesia and flexibility for acute pain management. Oxycodone exerts its effect by binding to and activating the mu-opioid receptor, altering pain perception and response in the central nervous system. Tolerance, dependence, and risk of misuse are considerations. No unique proprietary formulation for this specific combination is currently marketed, but the regimen is common in clinical practice for titrating analgesia based on patient needs[1][2][3][4].